Microorganisms in Recent Drug Discovery

Microorganisms  stay unrivalled in their ability to produce bioactive small molecules for drug development. Though, the core technologies used to discover microbial natural products have not evolved considerably over the past several decades, resulting in a shortage of new drug leads. Advances in DNA-sequencing and bioinformatics technologies currently build it possible to rapidly determine the clusters of genes that encode bioactive compounds and to make computer predictions of chemical structure based on gene sequence information. These structure predictions can be used to determine new chemical entities and supply necessary physicochemical “handles” that lead compound purification and structure confirmation. Industrialization of this process provides a model for rising the efficiency of natural-product discovery. The application of advanced genomics and bioinformatics technologies is  currently  poised to revolutionize natural-product discovery and lead a renaissance of interest in microorganisms as a supply of bioactive compounds for drug development.

    Related Conference of Microorganisms in Recent Drug Discovery

    November 19-19, 2021

    11th European Epidemiology and Public Health Congress

    Paris, France
    December 01-01, 2021

    4th International Conference on Tropical and Infectious Diseases

    Amsterdam, Netherlands
    February 07-08, 2022

    9th International Congress on Infectious Diseases

    Aberdeen, UK
    March 09-10, 2022

    VIROLOGY CONFERENCE-INFE-2022

    Geneva, Switzerland
    April 25-26, 2022

    4th World Congress on Advancements in Tuberculosis and Lung Diseases

    Singapore City, Singapore
    June 24-25, 2022

    14th Euro-Global Conference on Infectious Diseases

    Berlin, Aland Islands

    Microorganisms in Recent Drug Discovery Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in